Mateo Aboy

LML, University of Cambridge

Principal Research Scholar (PRA) in Biomedical Innovation, Precision Medicine, AI & Law

Trinity Ln

Cambridge, CB2 1TN

United Kingdom

http://www.lml.law.cam.ac.uk/people/Research-Scholars-Associates/Prof-mateo-aboy

  • LML, University of Cambridge

SCHOLARLY PAPERS

21

DOWNLOADS

3,782

SSRN CITATIONS

20

CROSSREF CITATIONS

3

Scholarly Papers (21)

Actions:
Email selected abstracts
1.

Cross-Border Transfers of Personal Data after Schrems II: Supplementary Measures and New Standard Contractual Clauses (SCCs)

Number of pages: 12 Posted: 27 Oct 2021
Marcelo Corrales Compagnucci, Mateo Aboy and Timo Minssen
Centre for Advanced Studies in Biomedical Innovation Law (CeBIL), Faculty of Law, University of Copenhagen, LML, University of Cambridge and University of Copenhagen - Centre for Advanced Studies in Biomedical Innovation Law (CeBIL) - Faculty of Law
Downloads 822 (52,298)
Citation 1

Abstract:

Loading...

Schrems II, international data transfers, supplementary measures, new Standard Contractual Clauses (SCCs), EDPB Recommendations 01/2020, encryption, security and organisational measures, GDPR.

2.

COVID-19 Contact Tracing Apps: A Stress Test for Privacy, the GDPR and Data Protection Regimes

Journal of Law and the Biosciences (2020), University of Cambridge Faculty of Law Research Paper No. 23/2020
Number of pages: 21 Posted: 03 Jun 2020
Laura R. Bradford, Mateo Aboy and Kathleen Liddell
Weill Cornell Medical College, LML, University of Cambridge and University of Cambridge - Faculty of Law
Downloads 790 (55,019)
Citation 7

Abstract:

Loading...

data privacy, information privacy, GDPR, HIPAA, COVID-19, contact tracing, data protection

3.

Towards Responsible Quantum Technology

Harvard Berkman Klein Center for Internet & Society Research Publication Series #2023-1, Harvard University 2023, https://cyber.harvard.edu/publication/2023/towards-responsible-quantum-technology
Number of pages: 22 Posted: 21 Mar 2023 Last Revised: 11 Jun 2023
Mauritz Kop, Mateo Aboy, Eline De Jong, Urs Gasser, Timo Minssen, I. Glenn Cohen, Mark Brongersma, Teresa Quintel, Luciano Floridi and Ray Laflamme
Stanford Law School, LML, University of Cambridge, University of Amsterdam, Harvard University - Berkman Klein Center for Internet & Society, University of Copenhagen - Centre for Advanced Studies in Biomedical Innovation Law (CeBIL) - Faculty of Law, Harvard Law School, Stanford University - Department of Materials Science and Engineering, European Centre on Privacy and Cybersecurity, Yale University - Digital Ethics Center and University of Waterloo
Downloads 715 (62,887)
Citation 1

Abstract:

Loading...

Responsible Quantum Technology, RRI, Quantum-ELSPI, SEA-Framework for Responsible Quantum Innovation, Safeguarding, Engaging, Advancing, Regulating Quantum Technology, Governance Act, Law, Ethics, Socio-Economics, Policy, Values, Standards, Norms, Principles, AI, Nano, Nuclear, Biosciences, Dual Use

4.

Supplementary Measures and Appropriate Safeguards for International Transfers of Personal Data after Schrems II

Number of pages: 27 Posted: 06 Apr 2022
Marcelo Corrales Compagnucci, Mark Fenwick, Mateo Aboy and Timo Minssen
Centre for Advanced Studies in Biomedical Innovation Law (CeBIL), Faculty of Law, University of Copenhagen, Kyushu University - Graduate School of Law, LML, University of Cambridge and University of Copenhagen - Centre for Advanced Studies in Biomedical Innovation Law (CeBIL) - Faculty of Law
Downloads 383 (134,548)

Abstract:

Loading...

International transfers, cross-border transfers of personal data, homomorphic encryption (HE), multiparty processing, new standard contractual clauses (SCCs), Schrems II, supplementary measures, appropriate safeguards

5.

The Effects of Myriad and Mayo on Molecular Test Development in the US and Europe: Interviews from the Frontline

22 Vanderbilt Journal of Entertainment & Technology Law 785, University of Cambridge Faculty of Law Research Paper 33/2019
Number of pages: 53 Posted: 29 May 2019 Last Revised: 21 May 2020
John Liddicoat, Kathleen Liddell and Mateo Aboy
King’s College London, University of Cambridge - Faculty of Law and LML, University of Cambridge
Downloads 251 (209,676)
Citation 2

Abstract:

Loading...

patent, patentable subject matter, patent eligibility, 35 USC 101, US, Europe, interviews, empirical, comparative

6.

Lost on the High Seas without a Safe Harbor or a Shield? Navigating Cross-Border Data Transfers in the Pharmaceutical Sector After Schrems II Invalidation of the EU-US Privacy Shield

European Pharmaceutical Law Review (EPLR), 4(3):153-160
Number of pages: 10 Posted: 28 Jan 2021 Last Revised: 10 Apr 2021
Marcelo Corrales Compagnucci, Timo Minssen, Claudia Seitz and Mateo Aboy
Centre for Advanced Studies in Biomedical Innovation Law (CeBIL), Faculty of Law, University of Copenhagen, University of Copenhagen - Centre for Advanced Studies in Biomedical Innovation Law (CeBIL) - Faculty of Law, University of Ghent, Faculty of Law and LML, University of Cambridge
Downloads 155 (324,443)
Citation 1

Abstract:

Loading...

GDPR, Data transfer, Schrems II case, data protection, data security, Privacy Shield, Standard Contractual Clauses (SCCs), pharmaceutical sector

7.

10 Principles for Responsible Quantum Innovation

Number of pages: 10 Posted: 21 Jun 2023
Mauritz Kop, Mateo Aboy, Eline De Jong, Urs Gasser, Timo Minssen, I. Glenn Cohen, Mark Brongersma, Teresa Quintel, Luciano Floridi and Ray Laflamme
Stanford Law School, LML, University of Cambridge, University of Amsterdam, Harvard University - Berkman Klein Center for Internet & Society, University of Copenhagen - Centre for Advanced Studies in Biomedical Innovation Law (CeBIL) - Faculty of Law, Harvard Law School, Stanford University - Department of Materials Science and Engineering, European Centre on Privacy and Cybersecurity, Yale University - Digital Ethics Center and University of Waterloo
Downloads 143 (346,402)
Citation 1

Abstract:

Loading...

Responsible Quantum Technology; Quantum Safeguarding; Engaging & Advancing; Quantum-AI Ethics & Governance; Regulation; Responsible Quantum Innovation; Quantum R&D; Responsible Research and Innovation (RRI)

8.

Myriad's Impact on Gene Patents

Nature Biotechnology, Vol. 34, No. 11, p. 1119-1123, Nov. 2016, University of Cambridge Faculty of Law Research Paper No. 58/2017
Number of pages: 8 Posted: 04 Aug 2017 Last Revised: 25 Jun 2019
Mateo Aboy, Kathleen Liddell, John Liddicoat and Cristina Crespo
LML, University of Cambridge, University of Cambridge - Faculty of Law, King’s College London and University of Cambridge
Downloads 115 (408,386)
Citation 2

Abstract:

Loading...

Patents, BRCA, Myriad, Gene Patents, Patent Publications, Empirical Analysis

9.

After Myriad, What Types of Claim Amendments Change a Patent Ineligible Isolated Gene Claim Into an Eligible Patent Claim That Is ‘Markedly Different’ From Nature?

35 Nature Biotechnology 820-825
Number of pages: 31 Posted: 22 May 2018
Mateo Aboy, John Liddicoat, Kathleen Liddell, Matthew Jordan and Cristina Crespo
LML, University of Cambridge, King’s College London, University of Cambridge - Faculty of Law, University of Cambridge - Faculty of Law and University of Cambridge
Downloads 96 (463,638)
Citation 2

Abstract:

Loading...

Patents, Patent Law, Biotechnology, Myriad, Gene Patents, US, Empirical Legal Research

10.

Response to USPTO’s Patent Eligibility Jurisprudence Study (Docket No.: PTO–P–2021–0032)

University of Cambridge Faculty of Law Research Paper No. 9/2023
Number of pages: 156 Posted: 11 Oct 2021 Last Revised: 05 Apr 2023
Mateo Aboy, Kathleen Liddell, Cristina Crespo, John Liddicoat and Matthew Jordan
LML, University of Cambridge, University of Cambridge - Faculty of Law, University of Cambridge, King’s College London and University of Cambridge - Faculty of Law
Downloads 92 (479,875)

Abstract:

Loading...

Patentable subject matter, Bilski, Mayo, Myriad, Alice, USPTO, empirical studies, innovation, diagnostics, gene patents, software

11.

Was the Myriad Decision a ‘Surgical Strike’ on Isolated DNA Patents, or Does it Have Wider Impacts?

36(12) Nature Biotechnology 1146
Number of pages: 6 Posted: 27 Jun 2019 Last Revised: 18 Sep 2019
Mateo Aboy, Cristina Crespo, Kathleen Liddell, John Liddicoat and Matthew Jordan
LML, University of Cambridge, University of Cambridge, University of Cambridge - Faculty of Law, King’s College London and University of Cambridge - Faculty of Law
Downloads 57 (621,101)
Citation 1

Abstract:

Loading...

patents, gene patents, Myriad, wider impacts, DNA, markedly different, naturally occurring compounds, empirical, Biotechnology, US

12.

Has the EU Incentive for Drug Repositioning Been Effective? An Empirical Analysis of the '+1' Regulatory Exclusivity

52(7) International Review of Intellectual Property and Competition Law 825
Number of pages: 27 Posted: 31 Aug 2021
John Liddicoat, Kathleen Liddell, Mateo Aboy and Jakob Wested
King’s College London, University of Cambridge - Faculty of Law, LML, University of Cambridge and Centre for Advanced Studies in Biomedical Innovation Law (CeBIL)
Downloads 49 (664,828)
Citation 1

Abstract:

Loading...

drug repositioning, regulatory exclusivities, patents, empirical study, intellectual property

13.

Continental Drift? Do European Clinical Genetic Testing Laboratories Have a Patent Problem?

European Journal of Human Genetics, 2019, University of Cambridge Faculty of Law Research Paper 32/2019
Number of pages: 12 Posted: 01 Apr 2019 Last Revised: 31 Oct 2019
John Liddicoat, Kathleen Liddell, Arlie McCarthy, Stuart Hogarth, Mateo Aboy, Dianne Nicol, Simon Patton and Michael M. Hopkins
King’s College London, University of Cambridge - Faculty of Law, Unversity of Cambidge, King’s College London, Dept of Social Science, Health & Medicine, LML, University of Cambridge, University of Tasmania, European Molecular Genetics Quality Network and University of Sussex
Downloads 48 (670,748)

Abstract:

Loading...

patents, genetic tests, Europe, patent law

14.

Repositioning Generic Drugs: Empirical Findings and Policy Implications

International Review of Intellectual Property & Competition Law | 53, pages 1287–1322 (2022)
Number of pages: 36 Posted: 21 Sep 2023
John Liddicoat, Kathleen Liddell, Jonathan J. Darrow, Mateo Aboy, Matthew Jordan, Cristina Crespo and Timo Minssen
King’s College London, University of Cambridge - Faculty of Law, Harvard Medical School, LML, University of Cambridge, University of Cambridge - Faculty of Law, University of Cambridge and University of Copenhagen - Centre for Advanced Studies in Biomedical Innovation Law (CeBIL) - Faculty of Law
Downloads 47 (676,768)

Abstract:

Loading...

patents, repurposing, repositioning, drugs, empirical

15.

Reply to C.D. Richter

European Journal of Human Genetics
Number of pages: 5 Posted: 24 May 2021
John Liddicoat, Kathleen Liddell, Arlie McCarthy, Stuart Hogarth, Mateo Aboy, Dianne Nicol, Simon Patton and Michael M. Hopkins
King’s College London, University of Cambridge - Faculty of Law, Unversity of Cambidge, King’s College London, Dept of Social Science, Health & Medicine, LML, University of Cambridge, University of Tasmania, European Molecular Genetics Quality Network and University of Sussex
Downloads 19 (892,167)

Abstract:

Loading...

patents, genetic testing, Europe

16.

The FDA De Novo Medical Device Pathway, Patents, and Anticompetition

Nature Biotechnology, vol. 38, 2020, pp. 1028–1029, University of Illinois College of Law Legal Studies Research Paper No. 21-24
Posted: 09 Aug 2021
Jacob S. Sherkow and Mateo Aboy
University of Illinois College of Law and LML, University of Cambridge

Abstract:

Loading...

patents, FDA, De Novo, 510(k), anticompetition, regulation, medical devices

17.

Mayo’s Impact on Patent Applications Related to Biotechnology, Diagnostics and Personalized Medicine

Mayo’s impact on patent applications related to biotechnology, diagnostics and personalized medicine. / Aboy, Mateo; Crespo, Cristina; Liddell, Kathleen; Minssen, Timo; Liddicoat, Johnathan, Nature Biotechnology, Vol. 37, 05.2019, p. 513-518.
Posted: 18 Aug 2020
Mateo Aboy, Cristina Crespo, Kathleen Liddell, Timo Minssen and John Liddicoat
LML, University of Cambridge, University of Cambridge, University of Cambridge - Faculty of Law, University of Copenhagen - Centre for Advanced Studies in Biomedical Innovation Law (CeBIL) - Faculty of Law and King’s College London

Abstract:

Loading...

18.

One Year After Vanda, Are Diagnostics Patents Transforming Into Methods of Treatment to Overcome Mayo-Based Rejections?

One year after Vanda, are diagnostics patents transforming into methods of treatment to overcome Mayo-based rejections? / Aboy, Mateo; Crespo, Cristina; Liddell, Kathleen ; Davey, Neal; Liddicoat, Johnathan; Minssen, Timo., Nature Biotechnology, Vol. 38, 09.03.2020, p. 279–283.
Posted: 18 Aug 2020
Mateo Aboy, Cristina Crespo, Kathleen Liddell, Davey Neill, John Liddicoat and Timo Minssen
LML, University of Cambridge, University of Cambridge, University of Cambridge - Faculty of Law, affiliation not provided to SSRN, King’s College London and University of Copenhagen - Centre for Advanced Studies in Biomedical Innovation Law (CeBIL) - Faculty of Law

Abstract:

Loading...

19.

How Does Emerging Patent Case Law in the US and Europe Affect Precision Medicine? How Will Today’s Patent Law Affect Tomorrow’s Innovation in the Areas of Biomarkers and Nature-Based Products; Diagnostics; and Algorithms, Big Data and AI?

Aboy, M., Liddell, K., Crespo, C. et al. How does emerging patent case law in the US and Europe affect precision medicine?. Nat Biotechnol 37, 1118–1125 (2019)
Posted: 18 Aug 2020
Mateo Aboy, I. Glenn Cohen, Kathleen Liddell, John Liddicoat, Cristina Crespo, Sara Gerke and Timo Minssen
LML, University of Cambridge, Harvard Law School, University of Cambridge - Faculty of Law, King’s College London, University of Cambridge, Pennsylvania State University, Dickinson Law and University of Copenhagen - Centre for Advanced Studies in Biomedical Innovation Law (CeBIL) - Faculty of Law

Abstract:

Loading...

20.

The EU-US Privacy Shield Regime for Cross- Border Transfers of Personal Data under the GDPR: What are the legal challenges and how might these affect cloudbased technologies, big data, and AI in the medical sector?

Lexxion, 2020
Posted: 14 Aug 2020
Timo Minssen, Claudia Seitz, Mateo Aboy and Marcelo Corrales Compagnucci
University of Copenhagen - Centre for Advanced Studies in Biomedical Innovation Law (CeBIL) - Faculty of Law, University of Ghent, Faculty of Law, LML, University of Cambridge and Centre for Advanced Studies in Biomedical Innovation Law (CeBIL), Faculty of Law, University of Copenhagen

Abstract:

Loading...

21.

Regulatory Responses to Medical Machine Learning

Journal of Law and the Biosciences, Volume 7, Issue 1, January-June 2020, lsaa002, https://doi.org/10.1093/jlb/lsaa002
Posted: 14 Aug 2020 Last Revised: 07 Jul 2021
Timo Minssen, Sara Gerke, Mateo Aboy, W. Nicholson Price II and I. Glenn Cohen
University of Copenhagen - Centre for Advanced Studies in Biomedical Innovation Law (CeBIL) - Faculty of Law, Pennsylvania State University, Dickinson Law, LML, University of Cambridge, University of Michigan Law School and Harvard Law School

Abstract:

Loading...

Medical Devices, Artificial Intelligence, Regulation